MedTrace Logo

Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section

NCT02703519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2016-09-09

No results posted yet for this study

Summary

This prospective, controlled, clinical, intervention study measures the number of uterine Cesarean section scars and median myometrial thickness of women who underwent two Cesarean sections six to nine months after their last Cesarean section using transvaginal ultrasound.

It is the purpose of the study to assess if a resection of the uterine scar from a previous Cesarean section during a second Cesarean section could lead to a decrease in risk for subsequent pregnancies.

Conditions

  • Scar; Previous Cesarean Section
  • Complications; Cesarean Section, Wound, Dehiscence

Interventions

PROCEDURE

resection of uterine scar tissue

resection of uterine scar tissue of a previous cesarean section during a second cesarean section

Sponsors & Collaborators

  • Otto-von-Guericke University Magdeburg

    collaborator OTHER

  • Martin-Luther-Universität Halle-Wittenberg

    lead OTHER

Principal Investigators

  • Gregor Seliger, Dr. med. · Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg

  • Michael Tchirikov, Prof. · Maternity Clinic/Perinatal Treatment Center, Halle University Hospital, Martin-Luther-Universität Halle-Wittenberg

  • Serben-Dan Costa, Prof. · Maternity Clinic, Magdeburg University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02703519 on ClinicalTrials.gov